SMAD₃ Promotes Expression and Activity of the Androgen Receptor in Prostate Cancer

Using RNA-seq, scientists revealed that SMAD3 knockdown decreased levels of androgen receptor (AR) and AR target genes, whereas SMAD4 or SMAD2 knockdown had little or no effect.